Core Viewpoint - FitLife Brands, Inc. has announced the acquisition of substantially all assets of Irwin Naturals, a nutritional supplement company, under Section 363 of the US Bankruptcy Code, with the transaction expected to close around August 8, 2025 [1][2]. Transaction Highlights - The purchase price for the acquisition is $42.5 million, which includes approximately $16 million of net working capital and equates to a pre-synergy acquisition multiple of less than 6x EBITDA [8][9]. - The combined revenue for the first full year of operation is anticipated to exceed $120 million, with adjusted EBITDA expected to be between $20-25 million [8][9]. About Irwin Naturals - Irwin Naturals, founded in 1994, generates approximately 4% of its revenue from online sales, 61% from wholesale sales to mass market customers, and 35% from wholesale sales to health food stores [3]. - Major mass market customers for Irwin include CVS, Walmart, Walgreens, and Costco Canada [3]. Rationale for the Transaction - The product lines of FitLife and Irwin are largely complementary, with Irwin strong in weight loss, sexual wellness, and body cleanse segments, while FitLife focuses on sports nutrition [5]. - The acquisition is expected to enhance revenue growth through complementary channel strengths, particularly in the food, drug, and mass market channels where FitLife currently has minimal revenue [6]. - FitLife anticipates operational synergies that will allow for more profitable operations of Irwin, including an expected reduction of approximately $1.5 million in SG&A costs [7]. Financing Arrangements - The transaction will be funded through a combination of cash on hand and a new committed term loan of $40.625 million, along with an upsized $10 million revolving credit facility from First Citizens Bank [8][9]. - Pre-synergy total leverage at closing is expected to be less than 2.25x EBITDA [8]. Company Performance Expectations - For the second quarter of 2025, FitLife expects a year-over-year revenue decline of approximately 4-5%, attributed mainly to the performance of a specific product under the Dr. Tobias brand [11][12]. - The company anticipates net income for the second quarter to be between $1.6 - 1.8 million, including transaction-related expenses [12].

Core Viewpoint - FitLife Brands, Inc. plans to report its financial performance for Q2 of fiscal 2025 on August 14, 2025 [1] Group 1: Financial Reporting - The financial performance report for Q2 fiscal 2025 will be released on August 14, 2025 [1] - An investor conference call is scheduled for August 14, 2025, at 4:30 pm ET [2] - Participants can join the call using specific dial-in numbers and a conference identification code [2] Group 2: Company Overview - FitLife Brands is a developer and marketer of nutritional supplements and wellness products [3] - The company offers over 250 different products, primarily marketed online and through GNC® franchise locations [3] - FitLife Brands is headquartered in Omaha, Nebraska [3]

Financial Data and Key Metrics Changes - Revenue for Q2 2025 was $115 million, a 4% increase year-over-year or 2% in constant currency [6][14] - Adjusted EBITDA for Q2 was $11 million, an 8% increase from $10 million in the prior year [6][22] - GAAP net income attributable to common shareholders was $5.3 million or $0.28 per diluted share, compared to $1.3 million or $0.07 per diluted share in the prior year [22] - Gross margin increased by 36 basis points to 71.7% compared to the previous year [20] Business Line Data and Key Metrics Changes - North America sales grew 4%, with digital sales increasing by 34% [10][15] - Asia Pacific sales increased by 5%, driven by a 27% increase in Japan [7][16] - Europe sales were up 1% but down 2% in constant currency, with Central Europe showing strong growth of 15% [12][19] Market Data and Key Metrics Changes - In North America, the digital business saw significant growth, contributing to overall sales growth [10][15] - Japan's sales growth was notable, with a consistent 20%+ growth for four consecutive quarters [16] - Taiwan and South Korea faced challenges due to a slowing macroeconomic environment, impacting sales growth [9][18] Company Strategy and Development Direction - The company is focused on long-term sustainable growth through strong consumer engagement and execution of sales and marketing strategies [6][7] - The strategy includes sharpening digital execution, stabilizing the core business in North America, and driving growth in key international markets [12][13] - The company is increasing its full-year guidance based on strong first-half performance and positive momentum [13][24] Management's Comments on Operating Environment and Future Outlook - Management acknowledged ongoing macroeconomic uncertainties but expressed confidence in the company's fundamentals and growth strategy [6][7] - The outlook for the second half of the year includes expectations for continued growth in North America and stabilization in Asia Pacific [55][56] - Management is optimistic about future growth prospects, particularly in digital sales and new product innovations [25][62] Other Important Information - The company repurchased 1.1 million shares for approximately $12.3 million during the first half of 2025 [23] - Inventory increased to $69.3 million as the company prepared for potential supply chain disruptions [23] Q&A Session Summary Question: Clarification on EBITDA guidance range - Management indicated that the range reflects confidence in North America and the digital business, with performance dependent on continued acceleration [27][28] Question: Insights on SG&A expenses and digital investment - Management confirmed increased digital investment in Q2, with plans to continue funding if strong returns are observed [32][34] Question: Impact of new product innovations - New products are expected to provide consumer energy and acquisition, with cumulative effects anticipated over time [61][62] Question: Capacity and potential partnerships - The company is exploring opportunities to leverage increased manufacturing capacity through organic growth and potential partnerships [40][41] Question: Growth expectations in North America and Asia - Continued acceleration in North America is expected, while Asia Pacific will see growth but at lower rates compared to previous quarters [51][55]

Core Viewpoint - Nature's Sunshine Products, Inc. reported a strong second quarter for 2025, with net sales of $115 million and adjusted EBITDA of $11 million, reflecting year-over-year increases of 4% and 8% respectively, driven by growth in Japan, Central Europe, and digital business initiatives [2][7]. Financial Performance - Net sales for the second quarter of 2025 were $114.8 million, up from $110.6 million in the same quarter of 2024, marking a 4% increase. Excluding foreign exchange impacts, net sales increased by 2% [3][7]. - Adjusted EBITDA rose to $11.3 million, an 8% increase from $10.4 million in the prior year quarter, primarily due to higher net sales [10]. - GAAP net income attributable to common shareholders increased to $5.3 million, or $0.28 per diluted share, compared to $1.3 million, or $0.07 per diluted share, in the same quarter of 2024 [9][10]. Segment Performance - Sales by region showed varied performance: - Asia: $52.7 million, up 5.4% - Europe: $21.7 million, up 0.6% - North America: $35.0 million, up 4.2% - Latin America and Other: $5.4 million, down 0.6% [3]. Cost and Expenses - Gross profit margin improved to 71.7% from 71.4% year-over-year, attributed to cost-saving initiatives despite foreign exchange challenges [4]. - Selling, general and administrative expenses (SG&A) increased to $43.7 million from $38.6 million, representing 38.1% of net sales compared to 34.9% in the previous year [5]. Income and Cash Flow - Operating income decreased to $4.3 million, or 3.7% of net sales, down from $5.6 million, or 5.1% of net sales, in the prior year [6]. - Net cash provided by operating activities for the first half of 2025 was $6.9 million, compared to $3.5 million in the same period of 2024 [11]. Outlook - The company expects full-year 2025 net sales to range between $460 million and $475 million, and adjusted EBITDA to range between $41 million and $45 million, reflecting an optimistic outlook despite macroeconomic uncertainties [12].

全粉色沉浸式展位，传递 "母婴友好" 初心 花颜 28—— 日 "养" 根基，状态吃饱不掉线 汇集 28 种自然养分，花颜 28 为女性提供全面支持。从日常补充，到孕期营养储备及产后修复，通过平 衡代谢需求，以细密滋养守护生命绽放，成为母婴健康路上的贴心伙伴。 metoday 展位以全粉色为主视觉，用柔和灯光与通透陈设构建起温暖治愈的沉浸式空间。不同于传统母 婴场景的刻意呈现，这里通过色彩与氛围的细腻表达，将 "母婴友好" 的理念融入每一处细节。温柔的 粉色基调呼应着女性对 "温和、安心" 的需求，通透的布局与舒适的动线让参观者在放松的氛围中感受 品牌温度。以自然舒展的姿态传递着品牌对母婴群体的重视，让 "自内而外的滋养" 从产品延伸至体 验，用氛围诉说这一女性需求的深层理解。 三大主推品亮相，构建营养解决方案 补铁爆珠 ——"红" 粉佳人，面若桃花不用妆 针对全年龄段女性气血需求，metoday 补铁爆珠以独特配方激活血红蛋白活力，让红润气色自然晕染。 无论是孕期妈妈还是职场女性，都能通过温和滋养重获元气，从容应对生活挑战。 虾青素 —— 日透 "光" 感，暗黄退散 聚焦内服防晒新趋势，虾青素以高活性抗氧化 ...

Core Viewpoint - USANA Health Sciences (USNA) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive outlook based on an upward trend in earnings estimates, which significantly influences stock prices [1][2]. Earnings Estimates and Stock Price Impact - The Zacks rating system is based on changes in earnings estimates, which are strongly correlated with near-term stock price movements. Institutional investors utilize these estimates to determine the fair value of stocks, leading to buying or selling actions that affect stock prices [3][4]. - Rising earnings estimates for USANA Health suggest an improvement in the company's underlying business, which could lead to an increase in stock price as investors respond positively to this trend [4]. Zacks Rank System - The Zacks Rank stock-rating system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly Zacks Rank 1 stocks generating an average annual return of +25% since 1988 [6]. - The Zacks rating system maintains a balanced distribution of "buy" and "sell" ratings across its universe of over 4,000 stocks, ensuring that only the top 20% receive a "Strong Buy" or "Buy" rating [8][9]. Earnings Estimate Revisions for USANA Health - For the fiscal year ending December 2025, USANA Health is expected to earn $2.62 per share, which remains unchanged from the previous year. However, the Zacks Consensus Estimate has increased by 0.4% over the past three months, indicating a positive trend in earnings expectations [7].

Core Insights - Natural Alternatives International, Inc. (NAI) has extended its partnership with The Juice Plus+ Company through a new multi-year Manufacturing Agreement for Juice Plus+ capsule and powder products sold in over 24 markets globally [1][2] Company Overview - NAI is a leading formulator, manufacturer, and marketer of customized nutritional supplements, providing a comprehensive range of services including scientific research, proprietary ingredients, product formulation, testing, marketing management, packaging design, and regulatory review [2] Partnership Details - The partnership extension reflects a shared commitment to delivering premium nutritional products backed by extensive scientific research, with both companies focused on enhancing the health-promoting properties of Juice Plus+ products [2] - Juice Plus+ CEO expressed satisfaction with the commercial relationship, highlighting NAI's commitment to quality and innovation, indicating that the contract extension will be mutually beneficial [2]

Core Insights - Lifeist Wellness Inc. has launched three new Mikra performance-focused daily essentials aimed at enhancing cognitive performance and mental resilience [1][2] - The new products include Magnesium Bis-Glycinate, Coenzymated B Complex, and Omega-3 with EPA & DHA, all manufactured in partnership with Designs for Health [1][5] - The introduction of these products aligns with Mikra's Mind-First Movement, which emphasizes mental performance as a foundation for overall high performance [2][6] Product Details - Magnesium Bis-Glycinate is designed to ease physical tension and support recovery by calming the nervous system, which is crucial for cognitive performance [5] - Coenzymated B Complex provides active forms of B vitamins that help in energy production and stress regulation, contributing to cognitive stamina and mood balance [5] - Omega-3 with EPA & DHA nourishes brain cell membranes and supports mood regulation, playing a vital role in cognitive clarity and emotional steadiness [5] Strategic Partnerships - Lifeist has partnered with Designs for Health, a company known for its high-quality nutritional supplements and commitment to research-driven formulations [4][2] - This collaboration aims to integrate clinical precision with real-world performance, enhancing the quality and effectiveness of Mikra's product offerings [2][4] Brand Philosophy - Mikra operates under the philosophy that the mind leads and the body follows, focusing on the connection between mental and physical performance [5][6] - The brand aims to set a new standard for total human performance by prioritizing cognitive and emotional resilience through targeted formulations [6]

Mikra partners with leading nutritional supplement brand Designs for Health to introduce new product formulations TORONTO, July 21, 2025 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSX.V: LFST; OTCQB: LFSWF; FRANKFURT: M5B0), a health-tech wellness company curating and building innovation at the forefront of consumer health, announces the availability of three new Mikra performance-focused daily essentials on wearemikra.com. The new products — Magnesium Bis-Glycinate, Coenzymated ...

Tensions between the US and China escalating beyond the trade war. From tech, China is a competitor to Taiwan and remember that spy balloon. State of our union is apparently under Chinese surveillance.Washington now working to defend the US military from surveillance. Congress and the president trying to prevent China from buying land near bases over national security concerns. And now one lawmaker saying the country is already inside them through a nutritional company selling protein powder and vitamins to ...